Rabies is a notoriously underreported and neglected disease of low-income countries. This study aims to estimate the public health and economic burden of rabies circulating in domestic dog populations, globally and on a country-by-country basis, allowing an objective assessment of how much this preventable disease costs endemic countries. We established relationships between rabies mortality and rabies prevention and control measures, which we incorporated into a model framework. We used data derived from extensive literature searches and questionnaires on disease incidence, control interventions and preventative measures within this framework to estimate the disease burden. The burden of rabies impacts on public health sector budgets, local communities and livestock economies, with the highest risk of rabies in the poorest regions of the world. This study estimates that globally canine rabies causes approximately 59,000 (95% Confidence Intervals: 25-159,000) human deaths, over 3.7 million (95% CIs: 1.6-10.4 million) disability-adjusted life years (DALYs) and 8.6 billion USD (95% CIs: 2.9-21.5 billion) economic losses annually. The largest component of the economic burden is due to premature death (55%), followed by direct costs of post-exposure prophylaxis (PEP, 20%) and lost income whilst seeking PEP (15.5%), with only limited costs to the veterinary sector due to dog vaccination (1.5%), and additional costs to communities from livestock losses (6%). This study demonstrates that investment in dog vaccination, the single most effective way of reducing the disease burden, has been inadequate and that the availability and affordability of PEP needs improving. Collaborative investments by medical and veterinary sectors could dramatically reduce the current large, and unnecessary, burden of rabies on affected communities. Improved surveillance is needed to reduce uncertainty in burden estimates and to monitor the impacts of control efforts. Rabies is a fatal viral disease largely transmitted to humans from bites by infected animals—predominantly from domestic dogs. The disease is entirely preventable through prompt administration of post-exposure prophylaxis (PEP) to bite victims and can be controlled through mass vaccination of domestic dogs. Yet, rabies is still very prevalent in developing countries, affecting populations with limited access to health care. The disease is also grossly underreported in these areas because most victims die at home. This leads to insufficient prioritization of rabies prevention in public health agendas. To address this lack of information on the impacts of rabies, in this study, we compiled available data to provide a robust estimate of the health and economic implications of dog rabies globally. The most important impacts included: loss of human lives (approximately 59,000 annually) and productivity due to premature death from rabies, and costs of obtaining PEP once an exposure has occurred. The greatest risk of developing rabies fell upon the poorest regions of the world, where domestic dog vaccination is not widely implemented and access to PEP is most limited. A greater focus on mass dog vaccination could eliminate the disease at source, reducing the need for costly PEP and preventing the large and unnecessary burden of mortality on at-risk communities.

Rabies is endemic to the Russian Federation. The disease incidence ranges between 2,000 and 4,000 cases annually. Between two and six cases in humans are also reported each year. Wild animals are the basic reservoir and vector of the virus, and the incidence of rabies in foxes and raccoon dogs amounts to 50% of the total number of disease cases. When outbreaks occur, the disease is also reported in domestic animals. To prevent the further spread of rabies, vaccination of domestic animals and oral immunisation of wildlife are practised. Unfortunately, vaccine coverage and disease prevention measures have not been sufficient to achieve a notable improvement in the rabies situation in the country. La rabia es endémica en la Federación de Rusia, con una incidencia que va de los 2 000 a los 4 000 casos anuales. Cada año se notifican entre dos y seis casos en el ser humano. Los animales silvestres son el principal reservorio y vector del virus: la incidencia de la rabia en zorros y mapaches supone el 50% de la totalidad de los casos. Cuando estallan brotes también se registran casos en animales domésticos. Para impedir que la enfermedad se siga propagando se procede a la vacunación de los animales domésticos y a la inmunización oral de la fauna silvestre. Lamentablemente, la cobertura de vacunación y las medidas de prevención no han bastado para lograr una mejora sustancial de la situación de la rabia. La rage est présente à l’état endémique dans la Fédération de Russie. Son incidence varie de 2 000 à 4 000 cas par an. Deux à six cas de rage humaine sont également enregistrés chaque année. Les animaux sauvages constituent le principal réservoir et vecteur du virus, l’incidence de la rage chez le renard et le chien viverrin représentant 50 % du nombre total de cas. En cas de foyer, la maladie affecte également les animaux domestiques. La vaccination des animaux domestiques et l’immunisation orale de la faune sauvage sont les deux mesures appliquées pour empêcher la rage de se propager davantage. Malheureusement, la couverture vaccinale obtenue et les mesures de prévention appliquées n’ont pas suffi à améliorer significativement la situation de la rage.

Prevention and control of rabies in the world will require international efforts to increase the availability and use of high quality cell-culture rabies vaccines for use in human and veterinary. An important aspect of activities to ensure such availability is transfer of technologies to developing countries for production of these vaccines. Methods for Rabies Virus manipulation have changed fundamentally from random attenuation to defined modifications. In 2001, WHO issued a resolution for the complete replacement of nerve tissue vaccines by 2006 with cell-culture rabies vaccines. However, sheep brain derived Fermi type rabies vaccine is still being manufactured and utilized for the majority of exposed patients in Ethiopia. Therefore, production of a safer and effective cell culture based anti-rabies vaccine is needed. Currently the Ethiopian government has heavily invested in upgrading the facilities required to produce a rabies vaccine in keeping with WHO recommendation. Rabies virus suspensions were obtained from vero cells cultivated on roller bottles after infection with the Pasteur virus strain (PV) and Evelyn Rokitniki Abelseth (ERA). Initially the titer of the obtained virus and multiplicity of infection of the viruses had to be optimized; therefore in rabies virus infected cultures, higher virus yields was obtained when infected with 0.001ERA virus/cell and incubated at 37°C in 5% CO2 for 96hr and 0.01PV/cell incubated at 37°C in 5% CO2 for 48hr. Based on the results it is conclude that, ERA virus 0.001ID/cell with incubation period of 96h and was selected as best titer for rabies vaccine production